This 2016 publication of In-Vitro Diagnostic Substance Manufacturing Industry report is the comprehensive source of research for the industry. The reader is informed of the latest industry information such as key financials, competitive landscape, cost and pricing, and important or shifting trends during the current environment, including the changes in output and shipment over the past months.
At 171 pages with over 152 charts and tables, the report topics cover current macroeconomic trends, product data, international trade, channel mix, government driven demand, and labor structure. It forecasts industry trends through 2020 on the domestic market, global market and overseas growth opportunities, leveraging historical data spanning more than a decade. This current research also reports on shipment data, inventory levels, international trade volume, and industry specific price indices available through July 2016. Industry analysts and Fortune 500 leaders rely on this quarterly report to plan and forecast accordingly to the industry’s dynamism.
In this report, you will find industry data on the following major categories:
Quick Industry Statistics: 2-page overview for the CEO on the run
Supply & Demand with Capacity Utilization
2005-2015 11-Year Historical Shipment & Revenue
2016-2020 5-Year Forecast
Industry Income Statement
All relevant financial data including: Revenue, Cost of Materials, Labor Costs, Gross Profit, SG&A, Net Income, etc.
4-year Financials Comparison and Trends
Industry Balance Sheet
Traditional key elements of Assets, Liabilities, and Equity
Inventory fabrication stages
Calculated balance sheet ratios
Plant additions and expansions
Computer and IT investments
Machinery and Equipment for production and material handling
Industry Cost Analysis
Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight
Materials and their percentage share of total material costs
Industry Pricing Analysis
Producer Pricing Indices at industry, wholesale, and retail levels for comparison and trend forecasting
Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories
Industry Foreign Trade
Labor and Compensation Structure: productivity indices, hourly wages, production hours, output index, HR structure
Establishments: Trends, Employee Statistics, State by State numbers
Valued added statistics: industry GDP contribution
Industry Concentration: HHI, number of companies, size distributions, market shares
Major Players: company profiles and market size ranges
Definition & Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. This 6-digit NAICS industry (325413) is under the hierarchy of Pharmaceutical and Medicine Manufacturing Industry (32541), Chemical Manufacturing Subsector (325), and the Manufacturing Sector (31-33). Its SIC equivalent code is: 2835 - In Vitro and In Vivo Diagnostic Substances (in-vitro diagnostic substances).
Revenue, Profitability & Foreign Trade Preview
The industry's revenue for the year 2015 was reported at $13.1 billion USD, with an estimated gross profit of 27.64%. The industry used a projected 65 percent of its full production capacity in 2015. The industry could have increased its total shipment value to $20.1 billion USD under full production capacity. This industry did not have direct foreign trade statistics. The report nevertheless depicted relevant foreign trade data from a higher level NAICS industry or industry group.
This industry report contains 171 pages of in-depth market research with over 150 charts and tables. Presented are current and forecasted U.S. industry sales and shipment data, and its global trade statistics. For financial analysis, the report presents industry level income statements, balance sheets, and capital expenditure figures. In the cost analysis section, 43 upstream industries are analyzed to offer insight into the supply chain cost structure. For the channel and pricing structure, 17 downstream industries are analyzed. The competitive landscape section provides the number of companies and their respective revenue share, the market concentration, and a list of major players. Furthermore, products within the industry are listed with their respective market sizes and import and export data. The appendices contain relevant resources to additional trade statistics, U.S. State statistics, and industry trade associations.
Our clients include Fortune 500 companies, manufacturers, international top consulting firms, major retailers and wholesalers, professional trade associations, financial corporations, universities, governmental entities, start-ups and individuals. We are committed to providing the highest level of quality to all our clients and assure your satisfaction in the report delivering as promised.